An AI-powered wearable for remote monitoring of patients has earned FDA clearance for hospital treatment in Class II. The AI-powered wearable device, developed by Current Health based in Edinburgh , Scotland, monitors patients continuously and automatically to help better determine a health trajectory and allows clinicians to intervene earlier.
Providers of healthcare in the USA and the UK. Are deploying Current to change their models of patient delivery from reactive to proactive care to produce better results for the patient. The current approach will help health organizations reduce unnecessary hospital readmissions for patients whose post-treatment conditions deteriorate — an expensive and cumbersome clinical burden that costs U.S. hospitals more than $40 billion annually, says a press release.
“To sustain our dedication to delivering world-class patient care, the Mount Sinai Health System partners with creative and leading-edge companies like Present. Continuous and proactive monitoring platform of Current has the potential to alert us to patient deterioration more quickly and give our team data insights that they can act on earlier, “said Dr. Scott Lorin, Mount Sinai Brooklyn president.
Currently has the largest physiological data set in real time , making it the most reliable, all-in-one wireless wearable currently approved for EU and US use. In addition to relevant contextual patient information, the proprietary algorithms of the company continuously analyze data to provide actionable and proactive insights into the health of the wearer. It seamlessly integrates with third-party devices to capture additional metrics, building patient-specific digital therapeutics and recommendations.
In the UK, Dartford and Gravesham NHS Trust are using Current which serves a local population of 500,000. These two hospitals use Current to monitor patients remotely after they are discharged. AI-powered wearable current use resulted in a 22 percent decrease in home visits and fewer hospital readmissions and visits to emergency departments, freing up skilled nursing time and helping patients feel safe and comfortable.
“We ‘re a small team of individuals at present committed to changing the world through proactive healthcare,” Current CEO Christopher McCann said. “Our team has worked hard to get here and it’s just the first step towards monitoring every human being’s health to identify sickness with the goal of saving lives earlier. We are in the hospital today, the home tomorrow and in the near future, we’ll be everywhere. We are just getting started.”
The most creative wearables event will be back at SEMICON West on 9-10 July to celebrate the 34th edition of the WT Wearable Technologies Conference Series in beautiful San Francisco. Topics include data analytics in professional sports, wearable prevention, treatment and rehabilitation, the future of digital health, medication and adherence, smart patches, optimisation of workflow and, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm,and many more.